3-38454328-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2
The NM_001106.4(ACVR2B):āc.6G>Cā(p.Thr2Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00003 in 1,298,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 31)
Exomes š: 0.000017 ( 0 hom. )
Consequence
ACVR2B
NM_001106.4 synonymous
NM_001106.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.346
Genes affected
ACVR2B (HGNC:174): (activin A receptor type 2B) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 3-38454328-G-C is Benign according to our data. Variant chr3-38454328-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 1285088.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-38454328-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.346 with no splicing effect.
BS2
High AC in GnomAd4 at 19 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACVR2B | ENST00000352511.5 | c.6G>C | p.Thr2Thr | synonymous_variant | 1/11 | 1 | NM_001106.4 | ENSP00000340361.3 | ||
ACVR2B | ENST00000465020.5 | n.10G>C | non_coding_transcript_exon_variant | 1/10 | 2 | |||||
ACVR2B-AS1 | ENST00000441531.1 | n.318+175C>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151512Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
19
AN:
151512
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000648 AC: 2AN: 30856Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 18508
GnomAD3 exomes
AF:
AC:
2
AN:
30856
Hom.:
AF XY:
AC XY:
0
AN XY:
18508
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000174 AC: 20AN: 1146542Hom.: 0 Cov.: 30 AF XY: 0.0000126 AC XY: 7AN XY: 554532
GnomAD4 exome
AF:
AC:
20
AN:
1146542
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
554532
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 151620Hom.: 0 Cov.: 31 AF XY: 0.0000944 AC XY: 7AN XY: 74140
GnomAD4 genome
AF:
AC:
19
AN:
151620
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
74140
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at